Opportunity Information: Apply for CDC RFA DP15 1511
Apply for CDC RFA DP15 1511
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills and Partnerships" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.068 Chronic Diseases Research, Control, and Prevention 93.135 Centers for Research and Demonstration for Health Promotion and Disease Prevention 93.328 National Implementation and Dissemination for Chronic Disease Preventio.
- This funding opportunity was created on Aug 10, 2015 and posted on Jun 10, 2015.
- Applicants must submit their applications by Aug 11, 2015 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $4,000,000.00 in funding.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Native American tribal governments (Federally recognized) For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) County governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public and State controlled institutions of higher education State governments Others (see text field entitled Additional Information on Eligibility for clarification) Public housing authorities/Indian housing authorities Special district governments Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility Private institutions of higher education.
- N/A
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The CDC cooperative agreement titled "Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills and Partnerships" focuses on improving health outcomes and quality of life for people living with systemic lupus erythematosus (SLE), an autoimmune disease that can cause widespread inflammation and damage across multiple organs and body systems. The opportunity is grounded in the reality that lupus is frequently misdiagnosed or diagnosed late, symptoms can be unpredictable and severe, and the burden of disease is not shared equally across the population. The announcement highlights major disparities by sex and race/ethnicity, noting that women are affected far more often than men, and that Black, American Indian/Alaska Native, and other minority groups experience much higher prevalence rates than White populations. CDC-backed lupus registries have strengthened the evidence base around incidence and prevalence, showing substantially higher rates among Black communities in Michigan and Georgia, and particularly high prevalence among American Indian/Alaska Native populations, with additional registry work expected to improve estimates for Hispanic and Asian communities. These data points are used to justify a national public health response that goes beyond clinical care and into sustained awareness, education, and community-based supports.
At its core, the grant is designed to build durable, nationwide capacity for lupus awareness and practical disease management support. The program aims to improve symptom recognition and diagnosis, strengthen lupus-related health communication, and expand the use and reach of evidence-based self-management education, physical activity, and strength training resources that can help people better manage day-to-day functioning and overall well-being. A major emphasis is placed on sustainability, meaning the work should not be a short-lived campaign but instead should create systems, partnerships, and dissemination channels that continue to function after the project period. The CDC also expects applicants to develop and maintain national partnerships, especially with community-based organizations, so that people with lupus can be referred to trustworthy clinical and community resources and so that educational materials and programs can be delivered consistently across many settings.
The announcement aligns the work with broader federal priorities, particularly Healthy People 2020 and CDCs chronic disease prevention goals. Lupus is treated as relevant to arthritis objectives in national surveillance frameworks, and the FOA ties the work to focus areas like access to health services, disability and health, health communication and health information technology, and health-related quality of life. In practice, this means award activities are expected to fit within a public health approach: monitoring and addressing chronic disease burden, translating research into usable interventions, improving systems and environments that support health, and explicitly working to reduce inequities in outcomes. The FOA also builds on a foundation of prior CDC investments, including multiple lupus registries across Georgia, Michigan, California, Manhattan, and the Indian Health Service, as well as longitudinal follow-up studies and formative research on lupus self-management tools and educational materials. Applicants are encouraged to connect their work to these prior efforts and to the National Public Health Agenda for Lupus (referenced as being developed around that time), so the new funding expands and coordinates with what has already been learned.
A key requirement is that applicants use a logic model approach to plan, implement, and evaluate the project. The expectation is that organizations will define long-term impacts (like better health outcomes and improved quality of life), then map backward to ensure that strategies, activities, and short-term outcomes are clearly connected and measurable. The target populations must include people with lupus, specifically SLE, with a strong emphasis on subpopulations experiencing disparities. The program also requires work with health care providers who care for SLE patients, recognizing that improving outcomes depends on both patient-facing support and provider knowledge, practices, and referrals. Applicants must describe how people with lupus and providers will be included in planning and implementation, reinforcing that the initiative is intended to be grounded in real patient and clinical needs rather than being purely top-down messaging.
Evaluation and performance measurement are central to the cooperative agreement model, where CDC remains actively involved through technical assistance and ongoing monitoring. The grantee is expected to build an evaluation plan with CDC guidance, using available data sources and leveraging registry and follow-up study findings as baseline information when appropriate. Performance measurement has two main parts: first, routine monitoring of progress on strategies and activities, tracked quarterly, including documentation of successes, barriers, and course corrections; and second, measurement of short-term outcomes, where awardees set targets (based on CDC guidance provided after award) and track metrics such as how many individuals with lupus and providers are reached by awareness efforts, how many evidence-based self-management and physical activity or strength programs are disseminated, and how many referrals are made to lupus-related clinical and community resources. CDC also notes that additional evaluation requirements could be added later via award terms, though any added reporting would remain within grants regulation limits.
The FOA places strong emphasis on organizational capacity, signaling that CDC is looking for applicants with demonstrated national reach and deep lupus-specific experience. Examples of desired capacity include being an organization devoted specifically to lupus, having a national structure with legally affiliated local networks, maintaining quality assurance standards, and being able to disseminate strategies to at least 25 states to achieve nationwide impact. It also highlights the need for professional health educators and the ability to provide direct support services, a proven track record running major lupus awareness campaigns (including the ability to handle increased phone and web inquiries), and demonstrated expertise in assessing community needs and translating them into messages that resonate and prompt action. Media capacity is also important, including the ability to engage different media types nationwide, distribute campaign materials effectively, and mobilize volunteer and private-sector talent from advertising and communications to amplify public health messaging.
From an administrative standpoint, this is a discretionary CDC cooperative agreement (not a formula grant), with an expected two awards and an estimated total funding level of about $2.5 million. The funding opportunity number is CDC RFA DP15-1511, and it lists a wide range of eligible applicants across government, nonprofit, education, tribal, and private sector categories, with no cost-sharing or matching requirement. CDC outlines an active monitoring and accountability approach that includes regular communication, potential site visits, and required programmatic and financial reporting. Post-award oversight focuses on whether recipients are on track to meet outcomes, whether data systems are adequate and credible, whether work plans match budgets and program intent, and whether adjustments are needed based on evaluation findings or changing conditions. The overall picture is a national-scale public health initiative meant to turn lupus surveillance findings and self-management research into practical, widely disseminated supports that improve recognition, care navigation, self-management skills, and ultimately health and quality of life, especially in communities bearing the greatest burden.
Frequently Asked Questions (FAQs)
What is the name of this CDC funding opportunity?
The cooperative agreement is titled "Developing and Disseminating Programs to Build Sustainable Lupus Awareness, Knowledge, Skills and Partnerships."
What is the funding opportunity number?
The funding opportunity number is CDC RFA DP15-1511.
What type of grant mechanism is this?
This opportunity is a discretionary CDC cooperative agreement. Under a cooperative agreement model, CDC remains actively involved through technical assistance and ongoing monitoring, rather than operating as a hands-off funder.
What health condition is the focus of this opportunity?
The opportunity focuses on systemic lupus erythematosus (SLE), an autoimmune disease that can cause widespread inflammation and damage across multiple organs and body systems.
Why is CDC funding a national lupus initiative like this?
The announcement frames lupus as a public health issue because it is frequently misdiagnosed or diagnosed late, symptoms can be unpredictable and severe, and the burden of disease is not shared equally across the population. CDC-backed lupus registries and related studies have strengthened evidence about incidence and prevalence, including substantially higher rates in certain communities, supporting the need for a broader public health response beyond clinical care alone.
What disparities does the announcement highlight?
The FOA highlights disparities by sex and race/ethnicity. It notes that women are affected far more often than men, and that Black, American Indian/Alaska Native, and other minority groups experience much higher prevalence rates than White populations. Registry findings cited include higher rates among Black communities in Michigan and Georgia, and particularly high prevalence among American Indian/Alaska Native populations. Additional registry work is described as expected to improve estimates for Hispanic and Asian communities.
What is the overall purpose of the cooperative agreement?
The overall purpose is to build durable, nationwide capacity for lupus awareness and practical disease management support, with the intent to improve health outcomes and quality of life for people living with SLE.
What kinds of outcomes is the program trying to improve?
The program is oriented toward long-term impacts such as better health outcomes and improved quality of life for people with lupus. It also emphasizes practical outcomes like improved symptom recognition and diagnosis, stronger lupus-related health communication, wider reach and use of evidence-based self-management education and physical activity/strength training resources, and stronger referral connections to trustworthy clinical and community resources.
Is this meant to be a short-term awareness campaign or something longer lasting?
The FOA places major emphasis on sustainability. The work is expected to create systems, partnerships, and dissemination channels that continue functioning after the project period, rather than being a one-time or short-lived campaign.
Who are the target populations for activities under this award?
The target populations must include people with lupus, specifically SLE, with a strong emphasis on subpopulations experiencing disparities. The program also requires engagement with health care providers who care for SLE patients, recognizing that outcomes depend on both patient-facing supports and provider knowledge, practices, and referrals.
Are applicants expected to include people with lupus and providers in planning?
Yes. Applicants must describe how people with lupus and providers will be included in planning and implementation, reinforcing that the initiative is intended to be grounded in patient and clinical needs rather than being purely top-down messaging.
What types of program activities does CDC expect?
Based on the FOA description, expected activities include improving symptom recognition and diagnosis through awareness and education; strengthening health communication related to lupus; expanding dissemination and use of evidence-based self-management education; and expanding physical activity and strength training resources that support day-to-day functioning and well-being. The FOA also emphasizes building and maintaining national partnerships to support consistent delivery and reliable referrals across many settings.
What does "evidence-based" mean in the context of this opportunity?
The FOA specifically calls for evidence-based self-management education and physical activity/strength training resources. The announcement also references prior CDC-supported formative research on lupus self-management tools and educational materials, suggesting applicants should build on and disseminate approaches supported by existing evidence and prior investments described in the FOA.
What role do partnerships play in this cooperative agreement?
Partnerships are a core expectation. Applicants are expected to develop and maintain national partnerships, especially with community-based organizations, to help ensure people with lupus can be referred to trustworthy clinical and community resources and to enable consistent delivery of educational materials and programs across many settings.
How does this opportunity connect to broader federal priorities?
The FOA aligns the work with Healthy People 2020 and CDC chronic disease prevention goals. It treats lupus as relevant to arthritis objectives in national surveillance frameworks and ties activities to focus areas such as access to health services, disability and health, health communication and health information technology, and health-related quality of life.
Does the FOA expect applicants to build on prior CDC lupus investments?
Yes. The FOA describes a foundation of prior CDC investments, including lupus registries (named as being across Georgia, Michigan, California, Manhattan, and the Indian Health Service), longitudinal follow-up studies, and formative research on self-management tools and educational materials. Applicants are encouraged to connect proposed work to these prior efforts and to the National Public Health Agenda for Lupus referenced in the announcement.
Is a logic model required?
Yes. A key requirement is the use of a logic model approach to plan, implement, and evaluate the project. The FOA expects applicants to define long-term impacts and map backward to ensure strategies, activities, and short-term outcomes are clearly connected and measurable.
What does CDC expect regarding evaluation?
Evaluation is central. The grantee is expected to build an evaluation plan with CDC guidance, use available data sources, and leverage registry and follow-up study findings as baseline information when appropriate.
What performance measurement and reporting does CDC describe?
The FOA describes two main parts of performance measurement: (1) routine quarterly monitoring of progress on strategies and activities, including documenting successes, barriers, and course corrections; and (2) measurement of short-term outcomes with targets set based on CDC guidance provided after award. Example metrics include how many individuals with lupus and providers are reached by awareness efforts, how many evidence-based self-management and physical activity/strength programs are disseminated, and how many referrals are made to lupus-related clinical and community resources.
Can CDC add additional reporting requirements after award?
CDC notes that additional evaluation requirements could be added later via award terms, with the condition that any added reporting would remain within grants regulation limits.
What does CDC mean by "active involvement" under a cooperative agreement?
The FOA describes active CDC involvement through technical assistance and ongoing monitoring. Oversight may include regular communication, potential site visits, and required programmatic and financial reporting, along with post-award review of progress toward outcomes, data system credibility, alignment of work plans with budgets and program intent, and adjustments informed by evaluation findings or changing conditions.
How many awards does CDC expect to make?
The FOA indicates an expectation of two awards.
What is the estimated total funding level?
The FOA describes an estimated total funding level of about $2.5 million.
Is there a cost-sharing or matching requirement?
No. The FOA states there is no cost-sharing or matching requirement.
Who is eligible to apply?
The FOA lists a wide range of eligible applicants across categories including government, nonprofit, education, tribal, and private sector organizations.
What organizational capacity does CDC appear to be looking for?
The FOA places strong emphasis on demonstrated national reach and deep lupus-specific experience. Examples include an organization devoted specifically to lupus; a national structure with legally affiliated local networks; quality assurance standards; ability to disseminate strategies to at least 25 states for nationwide impact; professional health educators; capacity to provide direct support services; a track record running major lupus awareness campaigns (including the ability to handle increased phone and web inquiries); expertise in assessing community needs and translating them into messages that resonate and prompt action; and media capacity to engage different media types nationwide, distribute campaign materials effectively, and mobilize volunteer and private-sector communications talent.
Does the FOA specify a geographic reach expectation?
Yes. The FOA highlights the ability to disseminate strategies to at least 25 states as an example of capacity needed to achieve nationwide impact.
What does dissemination mean in this context?
In the context of the FOA, dissemination refers to the ability to spread and support adoption of lupus awareness strategies, educational materials, and evidence-based programs (including self-management education and physical activity/strength training resources) across many settings and locations, supported by national partnerships and delivery channels.
What kinds of supports for people with lupus are emphasized beyond awareness?
Beyond awareness and education, the FOA emphasizes practical disease management supports, including evidence-based self-management education, physical activity, and strength training resources, as well as strengthening referral pathways to trustworthy clinical and community resources.
How does clinical care fit into this public health approach?
The FOA explicitly positions the work as going beyond clinical care into sustained awareness, education, and community-based supports. At the same time, it requires engagement with health care providers who care for SLE patients, reflecting the idea that improved outcomes rely on both community-facing programs and provider practices such as recognition, referral, and care navigation.
What data sources does the FOA mention as relevant to planning and evaluation?
The FOA references CDC-backed lupus registries and follow-up studies as sources that have strengthened the evidence base and may serve as baseline information when appropriate. It also notes additional registry work expected to improve estimates for Hispanic and Asian communities.
What are examples of the kinds of short-term outcomes CDC expects awardees to measure?
Examples provided include: the number of individuals with lupus reached by awareness efforts; the number of providers reached by awareness efforts; the number of evidence-based self-management and physical activity/strength programs disseminated; and the number of referrals made to lupus-related clinical and community resources.
What accountability and oversight should applicants anticipate after award?
The FOA describes an active monitoring and accountability approach that includes regular communication, possible site visits, and required programmatic and financial reporting. Post-award oversight focuses on progress toward outcomes, adequacy and credibility of data systems, whether work plans align with budgets and program intent, and whether course corrections are needed based on evaluation findings or changing conditions.
Browse more opportunities from the same category: Health
Next opportunity: Mount Rainier NP SCA Community Crews
Previous opportunity: HHS/ACL/NIDILRR Advanced Rehabilitation Research Training (ARRT) Program Advanced Rehabilitation Research Policy Fellowship CFDA Number 84.133P 5
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DP15 1511
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DP15 1511) also looked into and applied for these:
| Funding Opportunity |
|---|
| Regional AIDS Education and Training Centers Apply for HRSA 15 154 Funding Number: HRSA 15 154 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Research and Methods in Health Statistics Apply for RFA SH 16 001 Funding Number: RFA SH 16 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| TRANSFORM/PRIMARY HEALTH CARE UNIT (PHCU) Apply for RFA 663 15 000016 Funding Number: RFA 663 15 000016 Agency: Ethiopia USAID Addis Ababa Category: Health Funding Amount: $120,000,000 |
| Ryan White HIV/AIDS Program Part A HIV Emergency Relief Grant Program Apply for HRSA 16 021 Funding Number: HRSA 16 021 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIAMS Building Interdisciplinary Research Team (BIRT) Revision Awards (U01, U54, P01, P50, and P60) Apply for RFA AR 09 002 Funding Number: RFA AR 09 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Grant Program for Large Conference Support (R13) and (U13) Apply for PA 06 378 Funding Number: PA 06 378 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $100,000 |
| Development of Comprehensive Drug/Alcohol and Mental Health Treatment Systems for Persons Who are Homeless Apply for TI 09 006 Funding Number: TI 09 006 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $350,000 |
| Grants to Expand Substance Abuse Treatment Capacity for Adult Drug Courts Apply for TI 09 003 Funding Number: TI 09 003 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $300,000 |
| Offender Reentry Program Apply for TI 09 005 Funding Number: TI 09 005 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $400,000 |
| Grants for Primary and Behavioral Health Care Integration Apply for SM 09 011 Funding Number: SM 09 011 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $500,000 |
| Partnerships for Success State and Community Prevention Performance Grant Apply for SP 09 005 Funding Number: SP 09 005 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $2,300,000 |
| Health Promotion and Disease Prevention Apply for HHS 2009 IHS HPDP 0001 Funding Number: HHS 2009 IHS HPDP 0001 Agency: Indian Health Service Category: Health Funding Amount: $100,000 |
| Offender Reentry Program Apply for TI 10 006 Funding Number: TI 10 006 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $400,000 |
| Grants to Expand Substance Abuse Treatment Capacity for Juvenile Treatment Drug Courts Apply for TI 10 004 Funding Number: TI 10 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $325,000 |
| Grants to Expand Substance Abuse Treatment Capacity for Adult Drug Courts Apply for TI 10 011 Funding Number: TI 10 011 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $325,000 |
| Mental Health Transformation Grants Apply for SM 10 010 Funding Number: SM 10 010 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $750,000 |
| Grants to Expand Services to Children Affected by Methamphetamine in Families Participating in Family Treatment Drug Court Apply for TI 10 009 Funding Number: TI 10 009 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $370,000 |
| Capacity Building Initiative for Substance Abuse (SA) and HIV Prevention Services for At Risk Racial/Ethnic Minority Young Adults Apply for SP 10 004 Funding Number: SP 10 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $300,000 |
| Regional Collaborative for the Pacific Basin Apply for HRSA 10 120 Funding Number: HRSA 10 120 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Community Resilience and Recovery Initiative Apply for SM 10 015 Funding Number: SM 10 015 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $1,400,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DP15 1511", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.